- Atreca Inc Annual Shareholders Meeting TranscriptJun 13, 2023
- Q4 2022 Atreca Inc Earnings Call TranscriptMar 29, 2023€1.18 (+9.26%)Earnings
- Atreca Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Atreca Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Atreca Inc at Stifel Healthcare Conference TranscriptNov 15, 2022
- Atreca Inc at Cowen IO Next Summit (Virtual) TranscriptNov 11, 2022
- Atreca Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2022
- Atreca Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Atreca Inc Annual Shareholders Meeting TranscriptJun 08, 2022
- Atreca Inc at Cowen Oncology Innovation Summit: Insights for ASCO & EHA (Virtual) TranscriptJun 02, 2022
- Atreca Inc Phase 1b ATRC-101 Clinical Data Update Call TranscriptJul 29, 2021
- Atreca Inc Turning the Current Cancer Therapeutic Discovery Paradigm on its Head TranscriptFeb 21, 2021
Atreca Inc at H C Wainwright Global Investment Conference (Virtual) Transcript
Good afternoon, everyone. Thanks for joining our next presentation. My name is [Lander]. I'm a research associate at H.C. Wainwright. We're pleased to have you with us today. And it is now my pleasure to introduce our next presenter. Please join me in welcoming Tito Serafini, Chief Strategy Officer and Founder of Atreca, a clinical stage biopharmaceutical company focused on developing cancer immunotherapies.
Tito, welcome. And I'll turn it over to you.
Thank you very much for inviting us today, and I'm very happy to present here today at the H.C. Wainwright Conference. So in the interest of time, I will skip through.
Here's our forward-looking statements disclaimer. The entire presentation I'm using today is available on our website as well, and I will skip through some of the company highlights here in the interest of time to focus on what it is we do, why it works, and what our first view of our pipeline assets to give folks -- give you a very good idea, I hope.
What
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)